𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates

✍ Scribed by F. Peters; M. Fickers; F. Erdkamp; J. Wals; J. Wils; H. Schouten


Publisher
Springer
Year
2001
Tongue
English
Weight
48 KB
Volume
80
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


CEOP treatment results and validity of t
✍ C. S. Chim; Y. L. Kwong; A. K. W. Lie; C. K. Lee; R. Liang πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 2 views

From 1991 to 1997, we have treated 78 newly diagnosed patients with aggressive non-Hodgkin's lymphoma with a modified CHOP regimen in which epirubicin (60 mg/m 2 ) was used in place of doxorubicin (50 mg/m 2 ), i.e. CEOP (cyclophosphamide, epirubicin, vincristine and prednisolone). The median age wa

The effect of in vitro irradiation on mi
✍ Samuel Rotstein; Edward Baral; Henric Blomgren; Bo Johansson πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 381 KB πŸ‘ 2 views

Blood lymphocytes from 20 untreated patients with Hodgkin's disease were compared with those of 20 untreated patients with non-Hodgkin's lymphoma with regard to the responsiveness of the cells to PHA and ConA following exposure to varying doses of ionizing radiation in vitro. Lymphocytes from 19 of